Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase

Critical Care Medicine

Volumn 39, Issue 7, 2011, Pages 1692-1711

  Pathan, Nazima ^a   Franklin, Joanne L ^a   Eleftherohorinou, Hariklia ^a   Wright, Victoria J ^a   Hemingway, Cheryl A ^a   Waddell, Simon J ^d   Griffiths, Michael ^b,c   Dennis, Jayne L ^e   Relman, David A ^b,c   Harding, Sian E ^a   Levin, Michael ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF SUSSEX   (United Kingdom)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

genomics; interleukin 6; meningococcal; p38MAPK; sepsis; septic shock

Indexed keywords

INTERLEUKIN 6; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RNA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GENE MAPPING; GENETIC TRANSCRIPTION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFANT; INOTROPISM; MALE; MENINGOCOCCOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

EID: 79959661938     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182186d27     Document Type: Article

References (58)

1. Watson RS, Carcillo JA, Linde-Zwirble WT, et al: The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167:695-701 (Pubitemid 36801744)
2. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554 (Pubitemid 36437931)
3. Padkin A, Goldfrad C, Brady AR, et al: Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003; 31:2332-2338 (Pubitemid 37100836)
4. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310 (Pubitemid 32641789)
5. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150 (Pubitemid 36056721)
6. Boucek MM, Boerth RC, Artman M, et al: Myocardial dysfunction in children with acute meningococcemia. J Pediatr 1984; 105: 538-542 (Pubitemid 14003563)
7. Levin M, Quint PA, Goldstein B, et al: Recombinant bactericidal/ permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: A randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet 2000; 356: 961-967
8. Abraham E, Laterre PF, Garbino J, et al: Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med 2001; 29:503-510 (Pubitemid 32225290)
9. Opal SM, Fisher CJ Jr, Dhainaut JF, et al: Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 1997; 25:1115-1124 (Pubitemid 27310249)
10. Fourrier F, Chopin C, Huart JJ, et al: Doubleblind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993; 104:882-888 (Pubitemid 23268966)
11. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709 (Pubitemid 32204987)
12. Pathan N, Hemingway CA, Alizadeh AA, et al: Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet 2004; 363:203-209 (Pubitemid 38114718)
13. Song M, Kellum JA: Interleukin-6. Crit Care Med 2005; 33(Suppl):S463-S465 (Pubitemid 41785989)
14. Narazaki M, Witthuhn BA, Yoshida K, et al: Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proc Nat Acad Sci U S A 1994; 91:2285-2289 (Pubitemid 24092088)
15. Kishimoto T, Akira S, Taga T: IL-6 receptor and mechanism of signal transduction. Int J Immunopharmacol 1992; 14:431-438
16. Yu X, Kennedy RH, Liu SJ: JAK2/STAT3, not ERK1/2, mediates interleukin-6-induced ac-tivation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytes. J Biol Chem 2003; 278: 16304-16309 (Pubitemid 36799756)
17. Bellahcene M, Jacquet S, Cao XB, et al: Activation of p38 mitogen-activated protein kinase contributes to the early cardiodepressant action of tumor necrosis factor. J Am Coll Cardiol 2006; 48:545-555 (Pubitemid 44093944)
18. Crackower MA, Oudit GY, Kozieradzki I, et al: Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 2002; 110:737-749 (Pubitemid 35283963)
19. Haralambous E, Hibberd ML, Hermans PW, et al: Role of functional plasminogenactivator- inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children. Crit Care Med 2003; 31: 2788-2793 (Pubitemid 38010636)
20. Popper SJ, Shimizu C, Shike H, et al: Geneexpression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol 2007; 8:R261
21. Alizadeh A, Eisen M, Davis RE, et al: The lymphochip: A specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol 1999; 64:71-78 (Pubitemid 30329266)
22. Hubble J, Demeter J, Jin H, et al: Implementation of GenePattern within the Stanford Microarray Database. Nucleic Acids Res 2009; 1;37(Database Issue):D898-D901
23. Smyth GK: Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:3
24. Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B 1995; 57:289-300
25. Gentleman RC, Carey VJ, Bates DM, et al: Bioconductor: Open software development for computational biology and bioinformatics. Genome Biology 2004; 5:R80
26. Kanehisa M, Araki M, Goto S, et al: KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008; 36:D480-D484 (Pubitemid 351149770)
27. Mi H, Lazareva-Ulitsky B, Loo R, et al: The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 2005; 33:D284-D288 (Pubitemid 40207879)
28. Zarubin T, Han J: Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005; 15:11-18 (Pubitemid 41653958)
29. Liu Y, Shepherd EG, Nelin LD: MAPK phosphatases- Regulating the immne response. Nat Rev Immunol 2007; 7:202-212
30. Kumar S, Boehm J, Lee JC: p38 MAP kinases: Key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003; 2:717-726 (Pubitemid 37361787)
31. Kaminska B: MAPK signalling pathways as molecular targets for anti-inflammatory therapy-From molecular mechanisms to therapeutic benefits. Biochim Biophys Acta 2005; 1754:253-262 (Pubitemid 41797706)
32. Cuenda A, Rousseau S: p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 2007; 1773:1358-1375 (Pubitemid 47125981)
33. Pathan N, Sandiford C, Harding SE, et al: Characterization of a myocardial depressant factor in meningococcal septicemia. Crit Care Med 2002; 30:2191-2198 (Pubitemid 35191566)
34. Leblais V, Jo SH, Chakir K, et al: Phosphatidylinositol 3-kinase offsets cAMP-mediated positive inotropic effect via inhibiting Ca2-influx in cardiomyocytes. Circ Res 2004; 95: 1183-1190 (Pubitemid 39648209)
35. Waage A, Brandtzaeg P, Halstensen A, et al: The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989; 169:333-338 (Pubitemid 19035565)
36. Osuchowski MF, Connett J, Welch K, et al: Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit Care Med 2009; 37:1567-1573
37. Chang L, Karin M: Mammalian MAP kinase signalling cascades. Nature 2001; 410:37-40 (Pubitemid 32225829)
38. Hilger RA, Scheulen ME, Strumberg D: The Ras-Raf-MEK-ERK pathway in the treatment of cancer. Onkologie 2002; 25:511-518 (Pubitemid 36173389)
39. Yang M, Wu J, Martin CM, et al: Important role of p38 MAP kinase/NF-B signaling pathway in the sepsis-induced conversion of cardiac myocytes to a proinflammatory phenotype. Am J Physiol Heart Circ Physiol 2008; 294:H994-H1001 (Pubitemid 351253313)
40. Asaduzzaman M, Wang Y, Thorlacius H: Critical role of p38 mitogen-activated protein kinase signaling in septic lung injury. Crit Care Med 2008; 36:482-488 (Pubitemid 351158623)
41. Schumann RR, Pfeil D, Freyer D, et al: Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk-1, erk-2, and p38 in astrocytes. Glia 1998; 22:295-305 (Pubitemid 28159020)
42. Chopra M, Sharma AC: Distinct cardiodynamic and molecular characteristics during early and late stages of sepsis-induced myocardial dysfunction. Life Sci 2007; 81: 306-316 (Pubitemid 47030576)
43. Liu S, Feng G, Wang GL, et al: p38MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway. Eur J Pharmacol 2008; 584:159-165
44. Wang M, Sankula R, Tsai BM, et al: P38 MAPK mediates myocardial proinflammatory cytokine production and endotoxin-induced contractile suppression. Shock 2004; 21: 170-174
45. Ma XL, Kumar S, Gao F, et al: Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 1999; 99:1685-1691 (Pubitemid 29162480)
46. Shanley TP, Cvijanovich N, Lin R, et al: Genome- level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med 2007; 13:495-508 (Pubitemid 47585744)
47. Riedemann NC, Guo RF, Hollmann TJ, et al: Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J 2004; 18:370-372
48. Dhingra S, Sharma AK, Singla DK, et al: p38 and ERK1/2 MAPKs mediate the interplay of TNF-alpha and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol 2007; 293: H3524-H3531 (Pubitemid 350230896)
49. Checchia PA, Schierding W, Polpitiya A, et al: Myocardial transcriptional profiles in a murine model of sepsis: Evidence for the importance of age. Pediatr Crit Care Med 2008; 9:530-535
50. Cvijanovich N, Shanley TP, Lin R, et al: Validating the genomic signature of pediatric septic shock. Physiol Genomics 2008; 34: 127-134
51. Chen XL, Xia ZF, Wei D, et al: Role of p38 mitogen-activated protein kinase in Kupffer cell secretion of the proinflammatory cytokines after burn trauma. Burns 2003; 29: 533-539 (Pubitemid 36970144)
52. Mockridge JW, Marber MS, Heads RJ: Activation of Akt during simulated ischemia/ reperfusion in cardiac myocytes. Biochem Biophys Res Commun 2000; 270:947-952 (Pubitemid 30444812)
53. Talmor D, Applebaum A, Rudich A, et al: Activation of mitogen-activated protein kinases in human heart during cardiopulmonary bypass. Circ Res 2000; 86:1004-1007 (Pubitemid 30324314)
54. Dong X, Liu Y, Du M, et al: P38 mitogenactivated protein kinase inhibition attenuates pulmonary inflammatory response in a rat cardiopulmonary bypass model. Eur J Cardiothorac Surg 2006; 30:77-84 (Pubitemid 43870152)
55. Chen XL, Xia ZF, Yu YX, et al: p38 mitogenactivated protein kinase inhibition attenuates burn-induced liver injury in rats. Burns 2005; 31:320-330
56. Parasrampuria DA, de Boer P, Desai-Krieger D, et al: Single-dose pharmacokinetics and pharmacodynamics of RWJ 67657, a specific p38 mitogen-activated protein kinase inhibitor: A first-in-human study. J Clin Pharmacol 2003; 43:406-413 (Pubitemid 36368782)
57. Branger J, Van Den Blink B, Weijer S, et al: Anti-inflammatory effects of a p38 mitogenactivated protein kinase inhibitor during human endotoxemia. J Immunol 2002; 168: 4070-4077 (Pubitemid 34298414)
58. Su J, Cui X, Li Y, et al: SB203580, a p38 inhibitor, improved cardiac function but worsened lung injury and survival during Escherichia coli pneumonia in mice. J Trauma 2010; 68:1317-1327